Inpatient care for skin diseases in Germany: multi-source analysis on the current and future health care needs

Background: In Germany, skin diseases are mainly treated in the 115 dermatological hospitals. Methods: Health care and health economic analysis of dermatological inpatient care and prediction of future care needs based on primary and secondary data. Results: Outpatient and inpatient care for dermatologic treatment indications is predominantly provided by dermatology specialists. Inpatient treatment was provided for 833,491 cases in 2018, corresponding to 4.21 % of all inpatient cases (19,808,687). Most common treatment cases were: epithelial skin cancer (total 87,386, of which dermatology clinics 52,608), followed by melanoma (23,917/17,774), psoriasis (19,291/13,352), erysipelas (73,337/11,260), other dermatitis (12,671/10,842), atopic dermatitis (AD) (11,421/9,734), and herpes zoster (26,249/9,652). With an average length of stay of 5.69 days, dermatology hospitals were in the bottom third. The proportion of inpatient indications cared for in dermatology hospitals was highest for prurigo (95.2 %), pemphigus (94.9 %), parapsoriasis (94.6 %), pemphigoid (90.3 %), eczema other than AD (85.6 %), and AD (85.2 %). While the total number of inpatient treatment cases in Germany has increased by an average of 17.5 % between 2000 and 2018, this is the case for 26.6 % of skin diseases and over 150 % for individual ones. The projection of current to future inpatient care suggests a continued high demand for inpatient care by dermatology hospitals. Conclusion: Inpatient dermatological care will continue to be an indispensable component of qualified, socially necessary care in Germany.

Automated summary

In Germany, skin diseases are mainly treated in dermatological hospitals, with a high number of inpatient treatment cases in 2018. The most common cases include epithelial skin cancer and melanoma. The average length of stay is 5.69 days, and there is expected to be continued high demand for inpatient care for skin diseases in the future.